{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:22:22Z","timestamp":1789946542911,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:00:00Z","timestamp":1424476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:00:00Z","timestamp":1424476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Recent oral contraceptive (OC) use has been consistently associated with increased risk of breast cancer, but evidence on specific breast cancer subtypes is sparse.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We investigated recency and duration of OC use in relation to molecular subtypes of breast cancer in a pooled analysis of data from the African American Breast Cancer Epidemiology and Risk Consortium. The study included 1,848 women with estrogen receptor-positive (ER+) breast cancer, 1,043 with ER-negative (ER-) breast cancer (including 494 triple negative (TN) tumors, which do not have receptors for estrogen, progesterone, and human epidermal growth factor 2), and 10,044 controls. Multivariable polytomous logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for exposure categories relative to never use, controlling for potential confounding variables.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>OC use within the previous 5\u00a0years was associated with increased risk of ER+ (OR 1.46, 95% CI 1.18 to 1.81), ER- (OR 1.57, 95% CI 1.22 to 1.43), and TN (OR 1.78, 95% CI 1.25 to 2.53) breast cancer. The risk declined after cessation of use but was apparent for ER+ cancer for 15 to 19\u00a0years after cessation and for ER- breast cancer for an even longer interval after cessation. Long duration of use was also associated with increased risk of each subtype, particularly ER-.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Our results suggest that OC use, particularly recent use of long duration, is associated with an increased risk of ER+, ER-, and TN breast cancer in African American women. Research into mechanisms that explain these findings, especially the association with ER- breast cancer, is needed.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13058-015-0535-x","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T14:02:36Z","timestamp":1424440956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A case\u2013control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium"],"prefix":"10.1186","volume":"17","author":[{"given":"Traci N","family":"Bethea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A","family":"Troester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L","family":"Lunetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa V","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepper","family":"Schedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence N","family":"Kolonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,21]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713\u201327.","journal-title":"Lancet"},{"key":"535_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","volume":"70","author":"H Ma","year":"2010","unstructured":"Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, et al. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study. Cancer Res. 2010;70:575\u201387.","journal-title":"Cancer Res."},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa013202","volume":"346","author":"PA Marchbanks","year":"2002","unstructured":"Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025\u201332.","journal-title":"N Engl J Med."},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/aje\/kwn360","volume":"169","author":"L Rosenberg","year":"2009","unstructured":"Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR. A case\u2013control study of oral contraceptive use and incident breast cancer. Am J Epidemiol. 2009;169:473\u20139.","journal-title":"Am J Epidemiol."},{"key":"535_CR5","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","volume":"19","author":"DJ Hunter","year":"2010","unstructured":"Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, et al. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev. 2010;19:2496\u2013502.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","volume":"9","author":"M Urban","year":"2012","unstructured":"Urban M, Banks E, Egger S, Canfell K, O\u2019Connell D, Beral V, et al. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case\u2013control study. PLoS Med. 2012;9:e1001182.","journal-title":"PLoS Med."},{"key":"535_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.4065\/81.10.1290","volume":"81","author":"C Kahlenborn","year":"2006","unstructured":"Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc. 2006;81:1290\u2013302.","journal-title":"Mayo Clin Proc."},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.aje.a010265","volume":"151","author":"WY Huang","year":"2000","unstructured":"Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151:703\u201314.","journal-title":"Am J Epidemiol."},{"key":"535_CR9","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1158\/1055-9965.EPI-10-0428","volume":"19","author":"L Rosenberg","year":"2010","unstructured":"Rosenberg L, Boggs DA, Wise LA, Adams-Campbell LL, Palmer JR. Oral contraceptive use and estrogen\/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev. 2010;19:2073\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","volume":"23","author":"EF Beaber","year":"2014","unstructured":"Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, et al. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev. 2014;23:755\u201364.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR11","first-page":"1375","volume":"11","author":"M Kumle","year":"2002","unstructured":"Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women\u2019s Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev. 2002;11:1375\u201381.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/ijc.22970","volume":"121","author":"C Sweeney","year":"2007","unstructured":"Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, et al. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer. 2007;121:2517\u201323.","journal-title":"Int J Cancer"},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/1097-0215(20000815)87:4<591::AID-IJC20>3.0.CO;2-C","volume":"87","author":"C Van Hoften","year":"2000","unstructured":"Van Hoften C, Burger H, Peeters PH, Grobbee DE, Van Noord PA, Leufkens HG. Long-term oral contraceptive use increases breast cancer risk in women over 55\u00a0years of age: the DOM cohort. Int J Cancer. 2000;87:591\u20134.","journal-title":"Int J Cancer."},{"key":"535_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature."},{"key":"535_CR15","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492\u2013502.","journal-title":"JAMA."},{"key":"535_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1524-4741.2008.00622.x","volume":"14","author":"HG Kaplan","year":"2008","unstructured":"Kaplan HG, Malmgren JA. Impact of triple negative phenotype on breast cancer prognosis. Breast J. 2008;14:456\u201363.","journal-title":"Breast J."},{"key":"535_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10549-010-1191-6","volume":"127","author":"SL Ooi","year":"2011","unstructured":"Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race\/ethnicity. Breast Cancer Res Treat. 2011;127:729\u201338.","journal-title":"Breast Cancer Res Treat."},{"key":"535_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","volume":"52","author":"JS Reis-Filho","year":"2008","unstructured":"Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52:108\u201318.","journal-title":"Histopathology."},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007;109:1721\u20138.","journal-title":"Cancer."},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103:250\u201363.","journal-title":"J Natl Cancer Inst."},{"key":"535_CR21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1158\/1055-9965.EPI-11-0465","volume":"20","author":"JR Palmer","year":"2011","unstructured":"Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev. 2011;20:1883\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR22","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558\u201368.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, et al. Risk factors for triple-negative breast cancer in women under the age of 45\u00a0years. Cancer Epidemiol Biomarkers Prev. 2009;18:1157\u201366.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/1471-2407-13-584","volume":"13","author":"R Ritte","year":"2013","unstructured":"Ritte R, Tikk K, Lukanova A, Tjonneland A, Olsen A, Overvad K, et al. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer. 2013;13:584.","journal-title":"BMC Cancer."},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jnci\/djr030","volume":"103","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst. 2011;103:470\u20137.","journal-title":"J Natl Cancer Inst."},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10549-011-1616-x","volume":"130","author":"MM Gaudet","year":"2011","unstructured":"Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56\u00a0years or younger. Breast Cancer Res Treat. 2011;130:587\u201397.","journal-title":"Breast Cancer Res Treat."},{"key":"535_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10552-013-0332-8","volume":"25","author":"JR Palmer","year":"2014","unstructured":"Palmer JR, Ambrosone CB, Olshan AF. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control. 2014;25:309\u201319.","journal-title":"Cancer Causes Control."},{"key":"535_CR28","first-page":"56","volume":"50","author":"L Rosenberg","year":"1995","unstructured":"Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women\u2019s Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc. 1995;50:56\u20138.","journal-title":"J Am Med Womens Assoc."},{"key":"535_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109:123\u201339.","journal-title":"Breast Cancer Res Treat."},{"key":"535_CR30","doi-asserted-by":"publisher","first-page":"871250","DOI":"10.1155\/2009\/871250","volume":"2009","author":"CB Ambrosone","year":"2009","unstructured":"Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, et al. Conducting molecular epidemiological research in the Age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women. J Oncol. 2009;2009:871250.","journal-title":"J Oncol."},{"key":"535_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2288-13-71","volume":"13","author":"EV Bandera","year":"2013","unstructured":"Bandera EV, Chandran U, Zirpoli G, McCann SE, Ciupak G, Ambrosone CB. Rethinking sources of representative controls for the conduct of case\u2013control studies in minority populations. BMC Med Res Methodol. 2013;13:71.","journal-title":"BMC Med Res Methodol."},{"key":"535_CR32","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s10552-013-0299-5","volume":"24","author":"U Chandran","year":"2013","unstructured":"Chandran U, Zirpoli G, Ciupak G, McCann SE, Gong Z, Pawlish K, et al. Racial disparities in red meat and poultry intake and breast cancer risk. Cancer Causes Control. 2013;24:2217\u201329.","journal-title":"Cancer Causes Control."},{"key":"535_CR33","unstructured":"International Classification of Diseases for Oncology (ICD-O). Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. (Eds.). Third Edition, First Revision. World Health Organization, Geneva, Switzerland; 2013."},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B","volume":"77","author":"SM Gapstur","year":"1996","unstructured":"Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases. Cancer. 1996;77:1465\u201371.","journal-title":"Cancer."},{"key":"535_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.critrevonc.2009.09.002","volume":"76","author":"CA Parise","year":"2010","unstructured":"Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race\/ethnicity. Crit Rev Oncol Hematol. 2010;76:44\u201352.","journal-title":"Crit Rev Oncol Hematol."},{"key":"535_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jss.2007.03.085","volume":"143","author":"CU Ihemelandu","year":"2007","unstructured":"Ihemelandu CU, Leffall Jr LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res. 2007;143:109\u201318.","journal-title":"J Surg Res."},{"key":"535_CR37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med."},{"key":"535_CR38","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/ijc.24232","volume":"124","author":"T Dorjgochoo","year":"2009","unstructured":"Dorjgochoo T, Shu XO, Li HL, Qian HZ, Yang G, Cai H, et al. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer. 2009;124:2442\u20139.","journal-title":"Int J Cancer."},{"key":"535_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1006037823178","volume":"50","author":"G Ursin","year":"1998","unstructured":"Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat. 1998;50:175\u201384.","journal-title":"Breast Cancer Res Treat."},{"key":"535_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","volume":"6","author":"V Cogliano","year":"2005","unstructured":"Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol. 2005;6:552\u20133.","journal-title":"Lancet Oncol."},{"key":"535_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10552-008-9213-y","volume":"20","author":"KA Rosenblatt","year":"2009","unstructured":"Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, et al. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2009;20:27\u201334.","journal-title":"Cancer Causes Control."},{"key":"535_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","volume":"335","author":"PC Hannaford","year":"2007","unstructured":"Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study. BMJ. 2007;335:651.","journal-title":"BMJ."},{"key":"535_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1018435205695","volume":"8","author":"SE Hankinson","year":"1997","unstructured":"Hankinson SE, Colditz GA, Manson JE, Willett WC, Hunter DJ, Stampfer MJ, et al. A prospective study of oral contraceptive use and risk of breast cancer (Nurses\u2019 Health Study, United States). Cancer Causes Control. 1997;8:65\u201372.","journal-title":"Cancer Causes Control."},{"key":"535_CR44","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/bcr1514","volume":"8","author":"H Ma","year":"2006","unstructured":"Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50\u00a0years by estrogen and progesterone receptor status: results from a case\u2013control and a case\u2013case comparison. Breast Cancer Res. 2006;8:R39.","journal-title":"Breast Cancer Res."},{"key":"535_CR45","first-page":"1053","volume":"12","author":"M Cotterchio","year":"2003","unstructured":"Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev. 2003;12:1053\u201360.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/aje\/kwr145","volume":"174","author":"PP Bao","year":"2011","unstructured":"Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, et al. Association of hormone-related characteristics and breast cancer risk by estrogen receptor\/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol. 2011;174:661\u201371.","journal-title":"Am J Epidemiol."},{"key":"535_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","volume":"22","author":"FP Turkoz","year":"2013","unstructured":"Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22:344\u201350.","journal-title":"Breast."},{"key":"535_CR48","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/humrep\/der081","volume":"26","author":"A Iversen","year":"2011","unstructured":"Iversen A, Thune I, McTiernan A, Emaus A, Finstad SE, Flote V, et al. Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study. Hum Reprod. 2011;26:1519\u201329.","journal-title":"Hum Reprod."},{"key":"535_CR49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bjc.2011.254","volume":"105","author":"TJ Key","year":"2011","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer. 2011;105:709\u201322.","journal-title":"Br J Cancer."},{"key":"535_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1055\/s-0032-1308999","volume":"44","author":"GS Merki-Feld","year":"2012","unstructured":"Merki-Feld GS, Seeger H, Mueck AO. Proliferative effects of estradiol- or ethinylestradiol-progestogen combinations on human breast cancer cells in an intermitted and a long-term regimen. Horm Metab Res. 2012;44:415\u201321.","journal-title":"Horm Metab Res."},{"key":"535_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1006482418082","volume":"65","author":"E Isaksson","year":"2001","unstructured":"Isaksson E, von Schoultz E, Odlind V, Soderqvist G, Csemiczky G, Carlstrom K, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat. 2001;65:163\u20139.","journal-title":"Breast Cancer Res Treat."},{"key":"535_CR52","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-06-3895","volume":"67","author":"PB Gupta","year":"2007","unstructured":"Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res. 2007;67:2062\u201371.","journal-title":"Cancer Res."},{"key":"535_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2042-6410-3-4","volume":"3","author":"I Campesi","year":"2012","unstructured":"Campesi I, Sanna M, Zinellu A, Carru C, Rubattu L, Bulzomi P, et al. Oral contraceptives modify DNA methylation and monocyte-derived macrophage function. Biol Sex Differ. 2012;3:4.","journal-title":"Biol Sex Differ."},{"key":"535_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bcp.2004.04.030","volume":"68","author":"M Szyf","year":"2004","unstructured":"Szyf M, Pakneshan P, Rabbani SA. DNA methylation and breast cancer. Biochem Pharmacol. 2004;68:1187\u201397.","journal-title":"Biochem Pharmacol."},{"key":"535_CR55","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670\u20134.","journal-title":"N Engl J Med."},{"key":"535_CR56","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0140-6736(95)92632-1","volume":"345","author":"TJ Powles","year":"1995","unstructured":"Powles TJ, Hickish T. Breast cancer response to hormone replacement therapy withdrawal. Lancet. 1995;345:1442.","journal-title":"Lancet."},{"key":"535_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1023006000760","volume":"14","author":"MD Althuis","year":"2003","unstructured":"Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control. 2003;14:151\u201360.","journal-title":"Cancer Causes Control."},{"key":"535_CR58","first-page":"329","volume":"93","author":"PG Moorman","year":"2001","unstructured":"Moorman PG, Millikan RC, Newman B. Oral contraceptives and breast cancer among African-american women and white women. J Natl Med Assoc. 2001;93:329\u201334.","journal-title":"J Natl Med Assoc."},{"key":"535_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","volume":"151","author":"S Shapiro","year":"2000","unstructured":"Shapiro S, Rosenberg L, Hoffman M, Truter H, Cooper D, Rao S, et al. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives. Am J Epidemiol. 2000;151:396\u2013403.","journal-title":"Am J Epidemiol."},{"key":"535_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","volume":"27","author":"R Sitruk-Ware","year":"2013","unstructured":"Sitruk-Ware R, Nath A. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Pract Res Clin Endocrinol Metab. 2013;27:13\u201324.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"535_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2105\/AJPH.81.1.90","volume":"81","author":"BB Gerstman","year":"1991","unstructured":"Gerstman BB, Gross TP, Kennedy DL, Bennett RC, Tomita DK, Stadel BV. Trends in the content and use of oral contraceptives in the United States, 1964\u201388. Am J Public Health. 1991;81:90\u20136.","journal-title":"Am J Public Health."},{"key":"535_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","volume":"88","author":"MD Althuis","year":"2003","unstructured":"Althuis MD, Brogan DR, Coates RJ, Daling JR, Gammon MD, Malone KE, et al. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer. 2003;88:50\u20137.","journal-title":"Br J Cancer."},{"key":"535_CR63","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","volume":"74","author":"EF Beaber","year":"2014","unstructured":"Beaber EF, Buist DS, Barlow WE, Malone KE, Reed SD, Li CI. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49\u00a0years of age. Cancer Res. 2014;74:4078\u201389.","journal-title":"Cancer Res."},{"key":"535_CR64","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.contraception.2011.08.007","volume":"85","author":"PA Marchbanks","year":"2012","unstructured":"Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, et al. Oral contraceptive formulation and risk of breast cancer. Contraception. 2012;85:342\u201350.","journal-title":"Contraception."},{"key":"535_CR65","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA. 2012;307:491\u20137.","journal-title":"JAMA."},{"key":"535_CR66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","volume":"87","author":"AB Edelman","year":"2013","unstructured":"Edelman AB, Cherala G, Munar MY, Dubois B, McInnis M, Stanczyk FZ, et al. Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception. 2013;87:220\u20136.","journal-title":"Contraception."},{"key":"535_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","volume":"80","author":"AB Edelman","year":"2009","unstructured":"Edelman AB, Carlson NE, Cherala G, Munar MY, Stouffer RL, Cameron JL, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity. Contraception. 2009;80:119\u201327.","journal-title":"Contraception."},{"key":"535_CR68","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.contraception.2010.04.016","volume":"82","author":"AB Edelman","year":"2010","unstructured":"Edelman AB, Cherala G, Stanczyk FZ. Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception. 2010;82:314\u201323.","journal-title":"Contraception."},{"key":"535_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10552-013-0323-9","volume":"25","author":"CB Ambrosone","year":"2014","unstructured":"Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, Hong CC, McIlwain D, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women\u2019s Circle of Health Study. Cancer Causes Control. 2014;25:259\u201365.","journal-title":"Cancer Causes Control."},{"key":"535_CR70","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/1471-2407-13-475","volume":"13","author":"EV Bandera","year":"2013","unstructured":"Bandera EV, Chandran U, Zirpoli G, Gong Z, McCann SE, Hong CC, et al. Body fatness and breast cancer risk in women of African ancestry. BMC Cancer. 2013;13:475.","journal-title":"BMC Cancer."},{"key":"535_CR71","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/oxfordjournals.aje.a010275","volume":"151","author":"IJ Hall","year":"2000","unstructured":"Hall IJ, Newman B, Millikan RC, Moorman PG. Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol. 2000;151:754\u201364.","journal-title":"Am J Epidemiol."},{"key":"535_CR72","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1158\/1055-9965.EPI-07-0336","volume":"16","author":"JR Palmer","year":"2007","unstructured":"Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev. 2007;16:1795\u2013802.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"535_CR73","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.aje.a116907","volume":"138","author":"P Nischan","year":"1993","unstructured":"Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol. 1993;138:697\u2013703.","journal-title":"Am J Epidemiol."},{"key":"535_CR74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/ije\/12.1.84","volume":"12","author":"MJ Rosenberg","year":"1983","unstructured":"Rosenberg MJ, Layde PM, Ory HW, Strauss LT, Rooks JB, Rubin GL. Agreement between women\u2019s histories of oral contraceptive use and physician records. Int J Epidemiol. 1983;12:84\u20137.","journal-title":"Int J Epidemiol."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-015-0535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0535-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:09:23Z","timestamp":1728922163000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-015-0535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,21]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s13058-015-0535-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,21]]},"assertion":[{"value":"29 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}